{
 "as_of": "2026-11-06",
 "cmr": "jp-cm-kg/TSE-PRIME/4519",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# CHUGAI PHARMACEUTICAL CO.,LTD. (Prime Market: 4519) — research page\n\nAs of 2026-11-06 · jp-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is CHUGAI PHARMACEUTICAL CO.,LTD., listed on the Prime Market under ticker 4519, ISIN JP3519400000, LEI 529900T9LAII161DCN95. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 6 filings in the window 2025-11-06 to 2026-11-06, on 3 filing days, comprising 1 ad hoc, 3 regulatory filings and 2 results. The median gap between filing days is 62.0 days. The latest filing is dated 2026-07-27 and is a regulatory filing, 102 days before the record date of 2026-11-06. The Prime Market median is 10 filings, a median cadence gap of 29.0 days and a median latency of 70.0 days across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a median cadence gap of 49.5 days and a median latency of 85.0 days across 80 issuers.\n\n## Auditor\n\nThe auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this market's register has no lifecycle type map yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nFor the client category Qualified Institutional Investors, the outcome is not determinable, with no signal code. The reason given is that the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's own investor-relations page names 18 research houses: BofA Securities Japan Co., Ltd.; Citigroup Global Markets Japan Inc.; CLSA; Daiwa Securities Co. Ltd.; Goldman Sachs Japan Co., Ltd.; Jefferies (Japan) Limited; J.P. Morgan Securities plc; Macquarie Capital; Mizuho Securities Co., Ltd.; Morgan Stanley MUFG Securities Co., Ltd.; Morningstar; Nomura Securities Co., Ltd.; Sanford C. Bernstein Japan KK; SBI SECURITIES Co.,Ltd.; SMBC Nikko Securities Inc.; UBS Securities Japan Co., Ltd; Morgan Stanley; and MUFG Securities Co., Ltd.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)\n- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4519 (the disclosure lines)\n- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)\n- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XTBJ (the auditor)\n- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html (coverage)\n- https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4519 (the record)\n",
 "market": "JP",
 "node": "jp-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the JP vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "read_by": "EDINET XBRL-to-CSV facts (API v2 type=5, 有価証券報告書 docTypeCode 120) — element jpcrp_cor:AuditFirm1Consolidated",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XTBJ",
    "state": "sourced",
    "value": "有限責任 あずさ監査法人"
   },
   "auditor_firm_id": {
    "market": "JP",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "JP",
    "state": "not_on_record"
   },
   "changes": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "jp-cm-kg/TSE-PRIME/4519",
  "coverage": {
   "count": 18,
   "houses": [
    {
     "analyst": "Koichi Mamegano",
     "house": "BofA Securities Japan Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Hidemaru Yamaguchi",
     "house": "Citigroup Global Markets Japan Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Matthew Yan",
     "house": "CLSA",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Kazuaki Hashiguchi",
     "house": "Daiwa Securities Co. Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Akinori Ueda",
     "house": "Goldman Sachs Japan Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Stephen Barker",
     "house": "Jefferies (Japan) Limited",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Seiji Wakao",
     "house": "J.P. Morgan Securities plc",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Tony Ren",
     "house": "Macquarie Capital",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Hiroshi Tanaka",
     "house": "Mizuho Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Shinichiro Muraoka",
     "house": "Morgan Stanley MUFG Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Jay Lee",
     "house": "Morningstar",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Hiroyuki Matsubara",
     "house": "Nomura Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Miki Sogi",
     "house": "Sanford C. Bernstein Japan KK",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Ryuta Kawamura",
     "house": "SBI SECURITIES Co.,Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Hiroshi Wada",
     "house": "SMBC Nikko Securities Inc.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Atsushi Seki",
     "house": "UBS Securities Japan Co., Ltd",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "house": "Morgan Stanley",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    },
    {
     "analyst": "Shinichiro Muraoka",
     "house": "MUFG Securities Co., Ltd.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html",
     "result": "read: 18 of 33 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1557,
     "median_cadence_gap_days": 29,
     "median_filings": 10,
     "median_latency_days": 70,
     "name": "Prime Market"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 49.5,
     "median_filings": 8,
     "median_latency_days": 85,
     "name": "3250 Pharmaceutical"
    }
   },
   "by_type": {
    "ad_hoc": 1,
    "regulatory_filing": 3,
    "results": 2
   },
   "cadence_median_gap_days": 62,
   "filing_days": 3,
   "filings": 6,
   "latency_days": 102,
   "latest": [
    {
     "category": "135",
     "date": "2026-07-27",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YS1O",
     "title": "確認書",
     "type": "regulatory_filing"
    },
    {
     "category": "半期報告書 (half-year report)",
     "date": "2026-07-27",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YS1G",
     "title": "半期報告書－第116期(2026/01/01－2026/06/30)",
     "type": "results"
    },
    {
     "category": "臨時報告書 (extraordinary report)",
     "date": "2026-03-27",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XUQ4",
     "title": "臨時報告書",
     "type": "ad_hoc"
    },
    {
     "category": "235",
     "date": "2026-03-25",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XTCX",
     "title": "内部統制報告書－第115期(2025/01/01－2025/12/31)",
     "type": "regulatory_filing"
    },
    {
     "category": "135",
     "date": "2026-03-25",
     "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XTCL",
     "title": "確認書",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-07-27",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4519",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Prime Market"
   },
   "isin": {
    "read_by": "GLEIF ISIN list for the LEI (lei-records/<lei>/isins) (the one equity-pattern ISIN JP3…00x)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest (isin-lei-latest.zip, ISINs mapped to the LEI)",
    "state": "sourced",
    "value": "JP3519400000"
   },
   "jurisdiction": {
    "read_by": "EDINET code list (Edinetcode.zip, filer master with corporate number) (提出者種別)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip",
    "state": "sourced",
    "value": "Japan (EDINET domestic filer)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN JP3519400000)",
    "state": "sourced",
    "value": "529900T9LAII161DCN95"
   },
   "name": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "CHUGAI PHARMACEUTICAL CO.,LTD."
   },
   "sector": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English) (33-sector classification)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "3250 Pharmaceutical"
   },
   "security_type": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "JP",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "JPX listed-issuers workbook (data_e.xlsx, English)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx",
    "state": "sourced",
    "value": "4519"
   },
   "website": {
    "market": "JP",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "JP",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "JP",
  "node": "jp-cm-kg",
  "numbers_hash": "sha256:b4671767517af58171b1a594ba67770c478d24765aae0bf90c64059334e1526c",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "Qualified Institutional Investors"
   ],
   "outcomes": {
    "Qualified Institutional Investors": {
     "determinable": false,
     "reason": "the rule states a product scope and the subject's record carries no instrument class to place within it",
     "signal": null
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.jp-cm-kg.ai/book/aio.json",
    "door": "https://mcp.jp-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/jp/suitability-principle-fiea-article-40/r1",
   "section": "jp.aio.v6"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4519",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:b4671767517af58171b1a594ba67770c478d24765aae0bf90c64059334e1526c",
 "path": "/jp/TSE-PRIME/4519",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is CHUGAI PHARMACEUTICAL CO.,LTD., listed on the Prime Market under ticker 4519, ISIN JP3519400000, LEI 529900T9LAII161DCN95. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 6 filings in the window 2025-11-06 to 2026-11-06, on 3 filing days, comprising 1 ad hoc, 3 regulatory filings and 2 results. The median gap between filing days is 62.0 days. The latest filing is dated 2026-07-27 and is a regulatory filing, 102 days before the record date of 2026-11-06. The Prime Market median is 10 filings, a median cadence gap of 29.0 days and a median latency of 70.0 days across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a median cadence gap of 49.5 days and a median latency of 85.0 days across 80 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this market's register has no lifecycle type map yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For the client category Qualified Institutional Investors, the outcome is not determinable, with no signal code. The reason given is that the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's own investor-relations page names 18 research houses: BofA Securities Japan Co., Ltd.; Citigroup Global Markets Japan Inc.; CLSA; Daiwa Securities Co. Ltd.; Goldman Sachs Japan Co., Ltd.; Jefferies (Japan) Limited; J.P. Morgan Securities plc; Macquarie Capital; Mizuho Securities Co., Ltd.; Morgan Stanley MUFG Securities Co., Ltd.; Morningstar; Nomura Securities Co., Ltd.; Sanford C. Bernstein Japan KK; SBI SECURITIES Co.,Ltd.; SMBC Nikko Securities Inc.; UBS Securities Japan Co., Ltd; Morgan Stanley; and MUFG Securities Co., Ltd.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx"
  },
  {
   "for": "identity.isin",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4519"
  },
  {
   "for": "the halt flag",
   "source": "https://www.jpx.co.jp/markets/equities/suspended/index.html"
  },
  {
   "for": "the auditor",
   "source": "https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XTBJ"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.jp-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.chugai-pharm.co.jp/english/ir/share/analyst_coverage.html"
  },
  {
   "for": "the record",
   "source": "https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4519"
  }
 ],
 "title": "CHUGAI PHARMACEUTICAL CO.,LTD. (4519) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}